Cancer

News

FDA grants AZ's Imfinzi fast review in new lung cancer use

The FDA has granted AstraZeneca’s Imfinzi immunotherapy a faster six-month review in patients with extensive-stage small cell lung cancer.

Events

HW191105 World ADC London banner design 740 X 400px

Partner Content

World ADC London 2020

Maximise the Therapeutic Index of Your ADC Pipeline

News

Merck & Co's Keytruda shows promise with prostate cancer 'su...

A small proportion of men with advanced prostate cancer, who have exhausted all other treatment options, were ‘super responders’ to Merck & Co’s Keytruda (pembrolizumab) immunotherapy i

News

Conservatives shy away from drug price debate in election ma...

The Conservative Party has pledged to encourage R&D in the UK’s life science industry should it win the December general election, with its manifesto shying away from the measures to cr

Partner Content